Synopsys, Inc. $SNPS Shares Sold by Himension Capital Singapore PTE. LTD.

Himension Capital Singapore PTE. LTD. lowered its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 17.7% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 24,472 shares of the semiconductor company’s stock after selling 5,267 shares during the quarter. Synopsys comprises about 1.0% of Himension Capital Singapore PTE. LTD.’s portfolio, making the stock its 15th largest position. Himension Capital Singapore PTE. LTD.’s holdings in Synopsys were worth $12,546,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Saudi Central Bank acquired a new stake in shares of Synopsys during the first quarter worth about $26,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 53 shares during the last quarter. Independence Bank of Kentucky increased its stake in shares of Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares during the period. Princeton Global Asset Management LLC raised its holdings in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 53 shares during the last quarter. Finally, WPG Advisers LLC purchased a new stake in Synopsys in the first quarter valued at $34,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CAO Sudhindra Kankanwadi sold 9,873 shares of the firm’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares in the company, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert G. Painter bought 350 shares of the company’s stock in a transaction on Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the transaction, the director directly owned 2,291 shares in the company, valued at $974,683.04. This trade represents a 18.03% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on SNPS shares. Mizuho dropped their target price on Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a report on Thursday, September 11th. JPMorgan Chase & Co. cut their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. KeyCorp lowered their price target on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Citigroup started coverage on shares of Synopsys in a research report on Monday. They set a “buy” rating and a $580.00 price target on the stock. Finally, BNP Paribas began coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $556.33.

Synopsys Stock Down 0.7%

Synopsys stock opened at $401.61 on Wednesday. The stock has a 50-day simple moving average of $443.58 and a 200-day simple moving average of $509.46. The company has a market capitalization of $74.60 billion, a P/E ratio of 31.52, a PEG ratio of 5.02 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the company posted $3.43 earnings per share. Synopsys’s revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.